Títulos similares: 50 Years of Immunization—Steps Forward
- Why vaccines to HIV, HCV and Malaria have so far failed - Challenges to developing vaccines against immunoregulating pathogens
- mLife
- ImmunoMedicine
- Global Health Research and Policy
- Dynamical Models of Biology and Medicine
- Public Health Challenges
- BMC Medicine
- Integrative Multi-Omics in Biomedical Research
- BMC Public Health
- International Journal of One Health
- Journal of the International AIDS Society
- npj Health Systems
- Health Care Science
- BJPsych International
- Jurnal Ilmiah Kesehatan Sandi Husada
- GeoHealth
- Tobacco Prevention and Cessation
- Health Economics, Policy and Law
- Annals of Global Health
- Global Challenges
- Clinovate: Advances in Medicine and Healthcare
- Health Expectations
- Acta Universitatis Danubius: Administratio
- Gazeta Médica
Topic: non-COVID-19 vaccine
- Topic: South Kivu
- Topic: immunization
- Topic: vaccine misinformation
- Topic: vaccine reactogenicity
- Topic: adverse reactions
- Topic: adverse events following immunization
- Topic: vaccine injury compensation program
- Topic: cholera
- Topic: oral cholera vaccine
- Topic: vaccination campaign
- Topic: cost
- Topic: cost-effectiveness
- Topic: integration
- Topic: vaccination
- Topic: service delivery
- Topic: systematic review
- Topic: maternal and child health
- Topic: infant
- Topic: HIV
- Topic: malaria
- Topic: family planning
- Topic: poliomyelitis
- Topic: epidemiology
- Topic: vaccine coverage
- Topic: surveillance
- Topic: polio eradication
- Topic: pertussis
- Topic: vaccines
- Topic: diagnosis
- Topic: vaccine security
- Topic: global OPV stockpile
- Topic: immunization policy
- Topic: inactivated poliovirus vaccine (IPV)
- Topic: oral poliovirus vaccine (OPV)
- Topic: vaccine production and distribution
- Topic: global health security
- Topic: poliovirus containment
- Topic: vaccine
- Topic: microplanning
- Topic: microplan
- Topic: LMIC
- Topic: routine childhood vaccines
- Topic: newcomer
- Topic: immunizations
- Topic: access
- Topic: equity
- Topic: qualitative methods
- Topic: Strategic Advisory Group of Experts (SAGE) on Immunization
- Topic: SAGE
- Topic: World Health Organization advisory group
- Topic: global immunization policy
- Topic: immunization strategy
- Topic: vaccination policy
- Topic: vaccination recommendations
- Topic: vaccine hesitancy
- Topic: cancer
- Topic: pediatric
- Topic: immunocompromised
- Topic: public health
- Topic: influenza
- Topic: COVID-19
- Topic: respiratory syncytial virus
- Topic: outbreaks
- Topic: maternal vaccination
- Topic: vaccination week in the Americas
- Topic: pandemic preparedness and response
- Topic: life-course immunization
- Topic: coverage increase
- Topic: zero-dose
- Topic: LMICs
- Topic: hepatitis E
- Topic: HEV 239
- Topic: shorter schedule
- Topic: immunogenicity
- Topic: efficacy
- Topic: zero dose
- Topic: under-five vaccination
- Topic: human centered design
- Topic: advocacy
- Topic: community-centric intervention
- Topic: National Immunization Technical Advisory Groups
- Topic: NITAGs
- Topic: WHO–UNICEF Joint Reporting Form
- Topic: measles
- Topic: under-immunized
- Topic: vaccine inequity
- Topic: herpes zoster
- Topic: varicella zoster virus
- Topic: health policy
- Topic: Central Africa
- Topic: big catch-up
- Topic: peer learning
- Topic: measles, mumps, and rubella
- Topic: MMR
- Topic: Denmark
- Topic: school
- Topic: healthcare
- Topic: education
- Topic: economic outcomes
- Topic: HPV vaccination
- Topic: girls
- Topic: supplementary immunization activities
- Topic: coverage
- Topic: disparities
- Topic: Togo
- Topic: immunization equity
- Topic: children with disabilities
- Topic: low- and middle-income countries
- Topic: vaccine barriers
- Topic: vaccination strategies
- Topic: inclusive healthcare
- Topic: adult
- Topic: health workers
- Topic: pregnant women
- Topic: elderly
- Topic: chronic diseases
- Topic: Shigella
- Topic: children
- Topic: phase III study
- Topic: endpoints
- Topic: safety
- Topic: dengue
- Topic: Qdenga
- Topic: CYD-TDV
- Topic: TAK-003
- Topic: Wolbachia
- Topic: antibody-dependent enhancement
- Topic: mRNA vaccines
- Topic: school-based programs
- Topic: n/a
- Topic: thema EDItEUR::M Medicine and Nursing
Topic: Vibrio cholerae
- Topic: South Kivu
- Topic: immunization
- Topic: vaccine misinformation
- Topic: vaccine reactogenicity
- Topic: adverse reactions
- Topic: adverse events following immunization
- Topic: vaccine injury compensation program
- Topic: cholera
- Topic: oral cholera vaccine
- Topic: vaccination campaign
- Topic: cost
- Topic: cost-effectiveness
- Topic: integration
- Topic: vaccination
- Topic: service delivery
- Topic: systematic review
- Topic: maternal and child health
- Topic: infant
- Topic: HIV
- Topic: malaria
- Topic: family planning
- Topic: poliomyelitis
- Topic: epidemiology
- Topic: vaccine coverage
- Topic: surveillance
- Topic: polio eradication
- Topic: pertussis
- Topic: vaccines
- Topic: diagnosis
- Topic: vaccine security
- Topic: global OPV stockpile
- Topic: immunization policy
- Topic: inactivated poliovirus vaccine (IPV)
- Topic: oral poliovirus vaccine (OPV)
- Topic: vaccine production and distribution
- Topic: global health security
- Topic: poliovirus containment
- Topic: vaccine
- Topic: microplanning
- Topic: microplan
- Topic: LMIC
- Topic: routine childhood vaccines
- Topic: newcomer
- Topic: immunizations
- Topic: access
- Topic: equity
- Topic: qualitative methods
- Topic: Strategic Advisory Group of Experts (SAGE) on Immunization
- Topic: SAGE
- Topic: World Health Organization advisory group
- Topic: global immunization policy
- Topic: immunization strategy
- Topic: vaccination policy
- Topic: vaccination recommendations
- Topic: vaccine hesitancy
- Topic: cancer
- Topic: pediatric
- Topic: immunocompromised
- Topic: public health
- Topic: influenza
- Topic: COVID-19
- Topic: respiratory syncytial virus
- Topic: outbreaks
- Topic: maternal vaccination
- Topic: vaccination week in the Americas
- Topic: pandemic preparedness and response
- Topic: life-course immunization
- Topic: coverage increase
- Topic: zero-dose
- Topic: LMICs
- Topic: hepatitis E
- Topic: HEV 239
- Topic: shorter schedule
- Topic: immunogenicity
- Topic: efficacy
- Topic: zero dose
- Topic: under-five vaccination
- Topic: human centered design
- Topic: advocacy
- Topic: community-centric intervention
- Topic: National Immunization Technical Advisory Groups
- Topic: NITAGs
- Topic: WHO–UNICEF Joint Reporting Form
- Topic: measles
- Topic: under-immunized
- Topic: vaccine inequity
- Topic: herpes zoster
- Topic: varicella zoster virus
- Topic: health policy
- Topic: Central Africa
- Topic: big catch-up
- Topic: peer learning
- Topic: measles, mumps, and rubella
- Topic: MMR
- Topic: Denmark
- Topic: school
- Topic: healthcare
- Topic: education
- Topic: economic outcomes
- Topic: HPV vaccination
- Topic: girls
- Topic: supplementary immunization activities
- Topic: coverage
- Topic: disparities
- Topic: Togo
- Topic: immunization equity
- Topic: children with disabilities
- Topic: low- and middle-income countries
- Topic: vaccine barriers
- Topic: vaccination strategies
- Topic: inclusive healthcare
- Topic: adult
- Topic: health workers
- Topic: pregnant women
- Topic: elderly
- Topic: chronic diseases
- Topic: Shigella
- Topic: children
- Topic: phase III study
- Topic: endpoints
- Topic: safety
- Topic: dengue
- Topic: Qdenga
- Topic: CYD-TDV
- Topic: TAK-003
- Topic: Wolbachia
- Topic: antibody-dependent enhancement
- Topic: mRNA vaccines
- Topic: school-based programs
- Topic: n/a
- Topic: thema EDItEUR::M Medicine and Nursing